Skip to main content
All Posts By

Carevive

Carevive is a health technology company focusing on care management and patient engagement solutions to improve the quality of life and clinical outcomes of cancer patients. Sign up for our newsletter here.

Oncology Practice Changes During a Multistep Oncology Care Model Practice Transformation Project
Oncology Practice Changes During a Multistep Oncology Care Model Practice Transformation Project PostersResources

Oncology Practice Changes During a Multistep Oncology Care Model Practice Transformation Project

Authors: Debra Wujcik, PhD, RN1 ; Susie Owenby, RN1 ; Moh’d Khushman MD2 ; Daniel Cameron, MD2; Thomas Butler, MD2; Cathy Tinnea RN2, Austin Cadden MPH2, Jennifer Pierce, MD2, Sachin Gopalkrishna Pai, MD2 1  Carevive Systems, Inc, Miami, FL 2 University of South Alabama Mitchell Cancer Institute Background Treatment of lung cancer has seen a paradigm shift in recent years.…
Carevive
May 1, 2020
Carevive selected to be a part of Silicon Valley Health Batch X Program at Plug and Play!.
Carevive selected for Plug and Play Silicon Valley Health Batch X Program In The News

Carevive selected for Plug and Play Silicon Valley Health Batch X Program

We are delighted to announce that Carevive was selected to be a part of Silicon Valley Health Batch X Program at Plug and Play. The Plug and Play Health team evaluated over 900 startups across the globe, and approximately 30 companies were selected by their Corporate Partners to present at Plug and Play’s Selection Day on February 27, 2020, at…
Carevive
March 9, 2020
Technology Supported Patient-Reported Outcome Assessment in the Clinic and from Home in Patients with Chronic Lymphocytic Leukemia
Tablet Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at Home PostersResources

Tablet Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at Home

Carevive's Debra Wujcik, PhD, RN, AOCN, FAAN along with Jeannine M. Brant, PhD, AOCN, FAAN from Billings Clinic presented a poster at the 2019 MASCC/ISOO Annual Meeting titled "Tablet-Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at Home". Background Cancer pain prevalence is high (52%-77%) and includes pain flares and end-of-dose failure. Poorly controlled pain contributes…
Carevive
June 24, 2019
Cancer and Survivorship in 2019: A Look at the Numbers
Cancer Survivor Population Expected to Reach 22.1 Million by 2030 In The News

Cancer Survivor Population Expected to Reach 22.1 Million by 2030

One in sixteen people in the U.S. will be a cancer survivor by 2030, according to a new report by the American Cancer Society and the National Cancer Institute. The Cancer treatment and survivorship statistics, 2019 report, states that the numbers will soar from 16.9 million Americans with a history of cancer as of the 1st of January this year…
Carevive
June 20, 2019
Carevive to Present Two Posters at the 2019 MASCC/ISOO Annual Meeting
Carevive to Present Two Posters at the 2019 MASCC/ISOO Annual Meeting Events

Carevive to Present Two Posters at the 2019 MASCC/ISOO Annual Meeting

Carevive's Director of Research, Debra Wujcik, PhD, RN, FAAN, will be presenting two posters at the 2019 MASCC/ISOO Annual Meeting in San Francisco on June 21-23.  The posters explore the usage of Carevie's patient-reported outcomes (PROs) tools to assess cancer pain associated with severe flares and end-of-dose failure and how chronic lymphocytic leukemia (CLL) patients can benefit from the collection…
Carevive
June 20, 2019
Ethan Basch to Lead Carevive’s Scientific Advisory Board
Ethan Basch to Lead Carevive’s Scientific Advisory Board Press Releases

Ethan Basch to Lead Carevive’s Scientific Advisory Board

Patient-reported outcomes research pioneer, Ethan Basch, MD, MSc, FASCO will serve as Scientific Advisory Board Director to build health care technology company’s patient-reported outcomes (PRO) and RWE analytics platform. North Miami, Florida — February 26, 2019 — Carevive, a health technology company that builds cancer care management and patient engagement solutions to improve patient quality of life and clinical outcomes, announced…
Carevive
February 26, 2019
UAB Improves Physician Adherence to QOPI Metrics Using Carevive Adherence to QOPI Metrics for Breast Cancer Patients
Improving End-of-Life Care for Cancer Patients – An Advisory Board Company Profile on Carevive In The News

Improving End-of-Life Care for Cancer Patients – An Advisory Board Company Profile on Carevive

Advisory Board Company includes Carevive in a report detailing four tactics to improve quality and patient experience while reducing costs As published in The Advisory Board Company website. Improving care at the end-of-ife is a prime opportunity for cancer programs to drive quality, decrease costs, and enhance the patient and family experience. Aggressive end-of-life care that provides no clinical benefit,…
Carevive
February 15, 2019
Webinar - Demystifying implementation of ePROs in oncology clinical care
Carevive announces webinar focusing on electronic patient-reported outcomes (ePROs) EventsIn The News

Carevive announces webinar focusing on electronic patient-reported outcomes (ePROs)

Carevive will be hosting a webinar titled Demystifying implementation of ePROs in oncology clinical care on January 16th, 1 PM EST.  Speakers will include Ethan Basch, MD, MSc, Diane Baldwin RN, OCN, CBCN, and other Carevive presenters. Integrating patient-reported outcomes (PROs) into clinical practice is an increasingly promising strategy for improving patient engagement, symptom control, and clinical outcomes, including reducing avoidable hospitalizations and…
Carevive
December 19, 2018
Improving Management of Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
[Webinar] Improving Management of Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) Resources

[Webinar] Improving Management of Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

NOT FOR CME/CREDIT FOR REFERENCE ONLY Recorded On Thursday, December 6th, 2018 1:00 – 2:00 pm EST In 2018, there will be an estimated 164,690 new cases of prostate cancer (PC) in the U.S. and approximately 29,430 patients will die of the disease, making it the third-leading cause of cancer death in men (American Cancer Society , 2018). The majority…
Carevive
December 7, 2018